Proactive Investors - Run By Investors For Investors

Tissue Regenix enters key growth phase, chief exec Odell says

Tissue Regenix' (LON:TRX) chief executive Antony Odell talks to Proactive Investors about the appointment of new Group Finance Director Paul Devlin and the company's targets for 2017.

"Paul has got an immense amount of experience accumulated over many years in private equity and a number of group finance director roles. Essentially he has a very strong M&A background but also has been involved in assisting businesses in that key growth phase we are now entering as a company where we are focusing very much on commercial elements and profitability. His input will be critical in the coming years, " he says.

Meet Premier African Minerals Ltd, Anglo Asian Mining Plc and Thor Mining PLC at our event, London, 21 September 2017. Register here »
View full TRX profile View Profile

Tissue Regenix Group PLC Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use